Sign In
Buy FMS
$20.90
+0.350 (+1.70%)
At Close: Jun 03, 2026
11 High-Yield Dividend Aristocrats Perfect For The Coming Recession
01:15pm, Wednesday, 20'th Jul 2022 Seeking Alpha
In this article, I discuss about high-yield defensive dividend aristocrats that can help weather the recession. Click here to know them.
11 High-Yield Dividend Aristocrats Perfect For The Coming Recession
09:15am, Wednesday, 20'th Jul 2022
Fears of a recession are mounting, with BAC and Deutsche Bank now forecasting a mild downturn in 2023. A recession could even begin by December 2022. Even without a recession Morgan Stanley is confide
After Plunging 11.8% in 4 Weeks, Here's Why the Trend Might Reverse for Fresenius (FMS)
01:35pm, Tuesday, 19'th Jul 2022 Zacks Investment Research
The heavy selling pressure might have exhausted for Fresenius (FMS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts i
Here's Why You Should Retain Fresenius Medical (FMS) Stock Now
11:56am, Tuesday, 19'th Jul 2022 Zacks Investment Research
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
After Plunging 11.8% in 4 Weeks, Here's Why the Trend Might Reverse for Fresenius (FMS)
10:51am, Tuesday, 19'th Jul 2022
The heavy selling pressure might have exhausted for Fresenius (FMS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts i
Here's Why You Should Retain Fresenius Medical (FMS) Stock Now
09:19am, Tuesday, 19'th Jul 2022
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Fresenius (FMS) Faces Fraud Accusation From US Government
02:40pm, Thursday, 14'th Jul 2022 Zacks Investment Research
The Department of Justice of the U.S. government files a civil complaint against Fresenius (FMS), accusing it of defrauding Medicare and other healthcare programs by billing for unnecessary procedures
Fresenius (FMS) Faces Fraud Accusation From US Government
12:24pm, Thursday, 14'th Jul 2022
The Department of Justice of the U.S. government files a civil complaint against Fresenius (FMS), accusing it of defrauding Medicare and other healthcare programs by billing for unnecessary procedures
9 High-Yield Dividend Aristocrats You Haven't Considered But Definitely Should
01:45pm, Saturday, 09'th Jul 2022 Seeking Alpha
Dividend aristocrats are some of the most time-tested dividend blue-chips in America. But the world is full of top quality and very dependable dividend growth powerhouses.
V.F. Corp: A 4.4% Yielding Dividend Aristocrat Bargain You Don't Want To Miss
11:00am, Sunday, 19'th Jun 2022 Seeking Alpha
If VFC grows as analysts expect by 2025 and returns to historical mid-range fair value, it could deliver 87% total returns or 25% annually. Read more here.
Fresenius: Revisiting The Thesis - Still A Buy
03:44am, Sunday, 19'th Jun 2022
We'll take a look at Fresenius in order to determine if the company still represents a good investment opportunity. Given a recent share price weakness, it's not strange that some investors are wonder
My, Oh, My 11 Incredible High-Yield Dividend Aristocrat Bear Market Buys
04:00pm, Saturday, 18'th Jun 2022 Seeking Alpha
This bear market is the 2nd worst start to the year in US stock market history. Fortunately, the world's best high-yield blue-chips are ready to protect your hard-earned savings.
My, Oh, My 11 Incredible High-Yield Dividend Aristocrat Bear Market Buys
12:00pm, Saturday, 18'th Jun 2022
This bear market is the 2nd worst start to the year in US stock market history. And cracks are beginning to form in credit markets that could potentially send stocks falling even lower in the coming m
Here's Why You Should Retain Fresenius Medical (FMS) Stock Now
11:43am, Tuesday, 14'th Jun 2022 Zacks Investment Research
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Here's Why You Should Retain Fresenius Medical (FMS) Stock Now
09:18am, Tuesday, 14'th Jun 2022
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
